Quick answer
Moody'S Corporation (MCO) reported revenue of $7.72B and net income of $2.46B for the fiscal year ended 2025-12-31, up 8.9% from $7.09B the year before, per its 10-K filed with the SEC on 2026-02-18. Long-term debt stood at $6.99B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $7.72B | $2.46B | $6.99B |
| 2024 (FY ending 2024-12-31) | $7.09B | $2.06B | $7.43B |
| 2023 (FY ending 2023-12-31) | $5.92B | $1.61B | $7.00B |
| 2022 (FY ending 2022-12-31) | $5.47B | $1.37B | $7.39B |
| 2021 (FY ending 2021-12-31) | $6.22B | $2.21B | $7.41B |
| 2020 (FY ending 2020-12-31) | $5.37B | $1.78B | $6.42B |
| 2019 (FY ending 2019-12-31) | $4.83B | $1.42B | $5.58B |
| 2018 (FY ending 2018-12-31) | $4.44B | $1.31B | $5.68B |
| 2017 (FY ending 2017-12-31) | $4.20B | $1.00B | $5.41B |
| 2016 (FY ending 2016-12-31) | $3.60B | $266.6M | $3.36B |
Related
- MCD revenue, net income and debt history (McDONALD’S CORPORATION)
- MCHP revenue, net income and debt history (Microchip Technology Incorporated)
- MCK revenue, net income and debt history (McKESSON CORPORATION)
- MDB revenue, net income and debt history (Mongodb, Inc.)
- MDGL revenue, net income and debt history (Madrigal Pharmaceuticals, Inc.)
- MDLN revenue, net income and debt history (Medline Inc.)
- MDLZ revenue, net income and debt history (Mondelez International, Inc.)
- MDT revenue, net income and debt history (Medtronic plc)
Last updated 2026-10-16. Data only, not financial or tax advice.
Related answers
- MCO dividend history: MOODYS CORP /DE/ annual dividends per share
- MCO earnings report dates and EPS history (Moody'S Corporation)